Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Dementia

fluorodeoxyglucose f18 has been researched along with Dementia in 256 studies

Research

Studies (256)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (10.16)	18.7374
1990's	20 (7.81)	18.2507
2000's	75 (29.30)	29.6817
2010's	118 (46.09)	24.3611
2020's	17 (6.64)	2.80

Authors

Authors	Studies
Alavi, A; Coble, R; Khosravi, M; Newberg, AB	1
Booth, S; Ko, JH; Lee, CS; Park, KW	1
Abbas, LA; Haidar, H; Hajeer, S; Majzoub, RE	1
Ahn, BC; Jeong, SY; Kang, K; Ko, PW; Lee, HW; Lee, J; Lee, SW; Son, SH; Yoon, U	1
Nayak, GK; Shepherd, TM	1
Alavi, A; Borja, AJ; Hancin, EC; Revheim, ME; Zhang, V	1
Madeddu, G; Nuvoli, S; Spanu, A; Stazza, ML; Tanda, G	1
Davidson, T; Friedman, KP; Lotan, E; Shepherd, TM	1
Baroni, M; Bruun, M; Dottorini, ME; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Henriksen, OM; Koikkalainen, J; Law, I; Lötjönen, J; Mecocci, P; Simonsen, AH	1
Andersen, FL; Bruun, FJ; Eikenes, L; Hansen, AE; Henriksen, OM; Højgaard, L; Karlberg, A; Ladefoged, CN; Law, I; Øen, SK	1
Berti, V; Cappa, SF; Catricalà, E; Conca, F; Esposito, V; Filippi, M; Gasparri, C; Iannaccone, S; Magnani, G; Perani, D; Polito, C; Presotto, L; Pupi, A; Sala, A; Sorbi, S	1
Boenink, M; Isaacs, JD	1
Authier, FJ; Chalaye, J; David, JP; Emsen, B; Evangelista, E; Gracies, JM; Itti, E; Lerman, L; Villafane, G	1
Ahmed, O; Bangiyev, L; Clifton, MA; Clouston, S; Franceschi, AM; Franceschi, D; Naser-Tavakolian, K	1
Herscovitch, P	1
Cross, D; Minoshima, S; Mosci, K; Thientunyakit, T	1
Beg, MF; Chausse, G; Jenkins, LM; Ma, D; Popuri, K; Probst, S; Stocks, JK; Wang, L; Yee, E	1
Cabanel, N; Hooshyar Yousefi, B; Kircher, T; Librizzi, D; Luster, M; Riehl, E; Zavorotnyy, M	1
Boccardi, M; Garibotto, V; Herholz, K; Nobili, F; Nordberg, A; Picco, A; Ratib, O; Varrone, A	1
Almkvist, O; Antoni, G; Chiotis, K; Jonasson, M; Leuzy, A; Lubberink, M; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Savitcheva, I; Wall, A	1
Almkvist, O; Alongi, P; Bettinardi, V; Cerami, C; Chiotis, K; Gianolli, L; Iaccarino, L; Nordberg, A; Perani, D; Wall, A	1
Inui, Y; Ito, K; Kato, T; Kimura, Y; Kizawa, T	1
Ackl, N; Bartenstein, P; Barthel, H; Brendel, E; Brendel, M; Buerger, K; Catak, C; Danek, A; Levin, J; Meyer-Wilmes, J; Patt, M; Pogarell, O; Prix, C; Rominger, A; Sabri, O; Schildan, A; Schnabel, J; Schönecker, S; Unterrainer, M; Wagner, L	1
Devanand, DP; Kumar, D; Lan, MJ; Mann, JJ; Miller, JM; Ogden, RT; Parsey, RV; Pelton, GH; Pradhaban, G; Rubin-Falcone, H; Stern, Y; Zanderigo, F	1
Kuo, PH; Sawyer, DM	2
Benedet, AL; Gauthier, S; Kang, MS; Mathotaarachchi, S; Nair, V; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Struyfs, H; Therriault, J; Walpola, IC	1
Alberici, A; Borroni, B; Padovani, A; Paghera, B; Paola Caminiti, S; Perani, D; Pilotto, A; Premi, E; Presotto, L; Turrone, R	1
Catana, C; Chen, KT; Chonde, DB; Dickerson, BC; Izquierdo-Garcia, D; Levine, MA; Price, JC; Salcedo, S	1
Boeve, BF; Botha, H; Dickson, DW; Graff-Radford, J; Jack, CR; Jones, DT; Josephs, KA; Knopman, DS; Kremers, WK; Lowe, V; Machulda, MM; Mantyh, WG; Murray, ME; Parisi, JE; Petersen, RC; Przybelski, SA; Schwarz, CG; Wiste, HJ	1
Gordon, BA	1
Bagnoli, S; Berti, V; Ferrari, C; Lombardi, G; Lucidi, G; Nacmias, B; Piaceri, I; Polito, C; Pupi, A; Sorbi, S	1
Altomare, D; Boccardi, M; Festari, C; Frisoni, GB; Gandolfo, F; Nobili, F; Orini, S	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Nestor, P; Nobili, F; Orini, S; Van Laere, K; Walker, Z	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Law, I; Nestor, PJ; Nobili, F; Orini, S; Rivolta, J; Walker, Z	1
Chiang, GC	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Gandolfo, F; Garibotto, V; Nestor, P; Nobili, F; Orini, S; Walker, Z	1
Agosta, F; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Nestor, P; Nobili, F; Walker, Z	1
Black, SE; Kuo, PH; Mikulis, D; Rosa-Neto, P; Strafella, AP; Subramaniam, RM; Zukotynski, K	1
Cho, SH; Jang, H; Kim, HJ; Kim, SE; Kim, SJ; Kim, Y; Lee, JS; Lockhart, SN; Na, DL; Park, S; Rabinovici, GD; Seo, SW; Seong, JK; Shin, JH	1
Anderson, T; Chen, L; Ge, JJ; Liu, FT; Tang, YL; Wang, J; Wu, L; Yu, H; Yu, WB; Zhao, J; Zuo, CT	1
Elgazzar, AH; Sarikaya, A; Sarikaya, I	1
Egger, K; Rijntjes, M	1
Bormann, T; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Vach, W	1
Carnero-Pardo, C; Gómez-Río, M; Górriz, JM; Martínez-Lozano, MD; Ramírez, J; Sánchez-Vañó, R; Segovia, F; Sopena-Novales, P; Triviño-Ibáñez, E	1
Fernández-Guinea, S; Fernández-Mateos, C; Garcia, E; Mucientes, J; Pascual, ML; Vaquero, J; Zurita, M	1
Hasselbalch, SG; Henriksen, OM; Kaltoft, NS; Larsen, VA; Law, I; Marner, L	1
Acuff, SN; Mathotaarachchi, S; Osborne, D; Subramaniam, R; Zukotynski, K	1
Iaccarino, L; Perani, D; Sala, A	1
Bastianello, M; Biafore, F; Depetris, TS; Peralta, C	1
Harbishettar, V; Mangalore, S; Mukku, SSR; Nagaraj, C; Sivakumar, PT; Varghese, M	1
Buchert, R; Thiele, F; Wenzel, F; Young, S	1
Hoffmann, M	1
Bayer-Karpinska, A; Bürger, K; Coloma Andrews, L; Dichgans, M; Duering, M; Gschwendtner, A; Opherk, C; Rominger, A; Wollenweber, FA; Zietemann, V	1
Baker, M; Bouchard-Kerr, P; Dinelle, K; Feldman, HH; Gonzalez, M; Hsiung, GY; Jacova, C; Lee, H; Mackenzie, IR; McCormick, S; Rademakers, R; Sengdy, P; Sossi, V; Stoessl, AJ; Tawankanjanachot, I	1
Bradley, YC; Hinds, SR; Stocker, DJ	1
Davison, CM; O'Brien, JT	1
Assal, F; Baskin, A; Garibotto, V; Giannakopoulos, P; Perani, D; Ratib, O; Seimbille, Y	1
Clopton, D; Jason Druzgal, T	1
D'Souza, MM; Damle, N; Jaimini, A; Kushwaha, S; Mondal, A; Saw, S; Sharma, R; Tripathi, M	1
Arbizu, J; de Castro, P; Domínguez, I; Gállego Pérez-Larraya, J; Irimia, P; Luquin, MR; Martínez-Vila, E; Ortega-Cubero, S; Pagola, I; Pastor, P; Riverol, M; Viteri, C	1
Geist, CL; Kenna, HA; Rasgon, NL; Silverman, DH; Williams, KE; Wroolie, TE	1
Eberl, S; Feng, DD; Fulham, M; Lu, S; Wen, L; Xia, Y	1
Berly, L; Blanc, F; Cretin, B; de Seze, J; Jaulhac, B; Jung, B; Kleitz, C; Kremer, S; Namer, IJ; Philippi, N; Sellal, F	1
Beer, AJ; Delso, G; Drzezga, A; Eiber, M; Förster, S; Fürst, S; Grimmer, T; Habekost, C; Hitz, S; Nekolla, SG; Schwaiger, M; Souvatzoglou, M; Ziegler, S	1
Arbizu, J; Clavero, P; García-Eulate, R; García-García, D; Gasca-Salas, C; González-Redondo, R; Obeso, JA; Rodríguez-Oroz, MC; Zubieta, JL	1
Ashburner, J; Caroli, A; Castiglioni, I; Cerami, C; Della Rosa, PA; Frisoni, G; Friston, K; Gallivanone, F; Gilardi, MC; Perani, D; Prestia, A	1
Elias, A; Rowe, CC; Woodward, M	1
Colletti, PM; Grassetto, G; Marzola, MC; Musto, A; Perkins, AC; Rubello, D; Viniamury, S	1
Herholz, K	3
Brucher, N; Filleron, T; Mandegaran, R; Wagner, T	1
Marcus, C; Shivamurthy, VK; Subramaniam, RM; Tahari, AK	1
Begum, R; Bohnen, NI; Brown, RK; Frey, KA; Srinivasan, A; Thomas, AC	1
Cappa, SF; Cerami, C; Della Rosa, PA; Magnani, G; Marcone, A; Perani, D; Santangelo, R	1
Hyde, C; Martin, S; Sachpekidis, C; Smailagic, N; Ukoumunne, O; Vacante, M	1
Kang, H; Kim, E; Kim, H; Kim, YK; Lee, D; Lee, DS; Lee, H; Lee, Y	1
Cabello, J; Förster, S; Lukas, M; Nekolla, SG; Pyka, T; Ziegler, SI	1
Hosokai, Y; Mori, E; Nishio, Y; Takeda, A; Uchiyama, M; Yokoi, K	1
Cabrera-Martín, MN; Carreras, JL; Fernádez-Matarrubia, M; Matias-Guiu, J; Matias-Guiu, JA; Moreno-Ramos, T; Porta-Etessam, J; Valles-Salgado, M	1
Arbizu, J; Chételat, G; Drezgza, A; Garibotto, V; Hesse, S; Lammertsma, AA; Law, I; Morbelli, S; Pagani, M; Pappata', S; Payoux, P; Van De Giessen, E	1
Jiang, T; Liu, Y; Tan, L; Tan, MS; Wang, C; Wang, HF; Yu, JT; Zhang, DQ	1
Ballard, KJ; Burrell, JR; Hodges, JR; Leyton, CE; Piguet, O; Rowe, CC; Shimada, H; Taswell, C; Villemagne, VL; Yates, P	1
Bralet, MC; Buchsbaum, MS; DeCastro, A; Mitelman, SA; Shihabuddin, L	1
Beauregard, JM; Bergeron, D; Bouchard, RW; Fortin, MP; Guimond, J; Houde, M; Laforce, R; Poulin, S; Verret, L	1
Alexopoulos, P; Drzezga, A; Förster, S; Förstl, H; Goldhardt, O; Grimmer, T; Kurz, A; Ortner, M; Sorg, C; Wutz, C	1
Diehl-Schmid, J; Drzezga, A; Grimmer, T; Li, J; Perneczky, R; Shi, K; Titov, D; Yakushev, I; Zou, N	1
Arslan, E; Çermik, TF; Ekmekçioğlu, Ö; Emül, HM; Engin Akcan, ZF; Erkan, ME; Görtan, FA; Halaç, M; Sönmezoğlu, K	1
Inui, Y; Ito, K; Kato, T; Nakamura, A	1
Buchert, R; Estrella, M; Fiebach, J; Mäurer, A; Megges, H; Peters, O; Roberts, A; Steinhagen-Thiessen, E	1
Ding, Z; Ge, J; Guo, S; Liu, F; Liu, Z; Tang, Y; Wang, J; Wang, Y; Wu, J; Wu, P; Zuo, C	1
Bensaïdane, MR; Laforce, R	1
Apostolova, I; Buchert, R; Fiebach, JB; Lange, C; Mäurer, A; Ritter, K; Seybold, J; Spies, L; Steinhagen-Thiessen, E	1
Chu, LW; Ha, J; Lee, SC; Shea, YF	1
Au, L; Chan, AYY; Chen, S; Chu, WCW; Fan, F; Ho, CL; Ip, V; Kwok, TCY; Lam, BYK; Lau, AYL; Leung, EYL; Leung, TWH; Liu, W; Ma, SH; Mok, VCT; Shi, L; Soo, YOY; Wang, Z; Wong, A; Wong, LKS; Yang, J	1
Cappa, SF; Cerami, C; Dodich, A; Greco, L; Iannaccone, S; Magnani, G; Marcone, A; Pelagallo, E; Perani, D; Santangelo, R	1
Lee, J; Silverman, DH; Torosyan, N	1
Drzezga, A; Mallik, AK; Minoshima, S	1
Cho, SG; Choi, KH; Choi, SM; Kang, SR; Kim, BC; Kim, J; Kwon, SY; Song, HC; Song, M	1
Aoki, M; Baba, T; Hasegawa, T; Hirayama, K; Hosokai, Y; Kikuchi, A; Mori, E; Nishio, Y; Suzuki, K; Takeda, A	1
Braskie, MN; Carmichael, OT; DeCarli, C; Maillard, P; Scott, JA; Thompson, PM; Tosun, D; Weiner, M	1
de Ceballos, ML; Köfalvi, A	1
Ishii, K; Kanda, T; Kono, AK; Miyamoto, N; Mori, E; Uemura, T; Yoshikawa, T	1
Castelnovo, G; Collombier, L; Labauge, P; Laplanche, JL; Remy, A; Renard, D	1
Peskind, ER	1
Dronkers, NF; Furst, AJ; Gorno-Tempini, ML; Jagust, WJ; Lal, RA; Miller, BL; Mormino, EC; O'Neil, JP; Ogar, JM; Rabinovici, GD; Racine, CA	1
An, YS; Lee, PH; Yong, SW	1
Coppola, C; Cotrufo, R; Di Fede, G; Formisano, S; Giaccone, G; Lavorgna, A; Leonardi, A; Mauro, C; Nigro, M; Piscosquito, G; Puoti, G; Tagliavini, F	1
Doppler, S; Hertl, C; Knell, U; Pichler, R; Szalay, E; Winkler, J	1
Eberl, S; Feng, D; Fulham, M; Wen, L; Xia, Y	1
Belliard, S; de la Sayette, V; Desgranges, B; Eustache, F; Laisney, M; Matuszewski, V; Mézenge, F	1
Boecker, H; Drzezga, A; Feurer, R; Förstl, H; Granert, O; Häussermann, P; Kurz, A; Perneczky, R	1
Almubarak, S; Gan, YC; Goddard, K; Hendson, G; Hukin, J; Nadel, H; Poskitt, K; Steinbok, P	1
Campbell, A; McCarthy, M; Panegyres, PK; Rogers, JM; Wu, JS	1
Fujishiro, H; Iseki, E; Kawano, M; Miki, S; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R	1
Barthel, H; Becker, G; Dukart, J; Frisch, S; Horstmann, A; Möller, HE; Mueller, K; Sabri, O; Schroeter, ML; Villringer, A; Vogt, B	1
Chang, KW; Chen, CC; Lee, SY; Wang, HE	1
Brugnolo, A; Dessi, B; Larsson, SA; Mazzei, D; Morbelli, S; Nobili, F; Pagani, M; Piccini, A; Rodriguez, G; Salmaso, D; Villavecchia, G	1
Apostolova, I; Arlt, S; Buchert, R; Jahn, H; Thiele, F; Wenzel, F; Wilke, F; Young, S	1
Chui, HC; Jagust, W; Kuczynski, B; Madison, C; Reed, B; Targan, E; Weiner, M; Zhang, Y	1
Asada, T; Fukuyama, H; Hashikawa, K; Takaya, S; Takayama, Y; Yamauchi, H	1
Albin, RL; Burke, JF; Frey, KA; Gilman, S; Giordani, B; Kilbourn, MR; Koeppe, RA	1
Fotopoulos, A; Kyritsis, AP; Sioka, C	1
Brodeur, C; Durand-Martel, P; Paquet, N; Tremblay, D	1
Bouchard, RW; Buteau, JP; Houde, M; Laforce, R; Paquet, N; Verret, L	1
Barkhof, F; Blankenstein, MA; Bouwman, FH; Klein, M; Kok, A; Scheltens, P; Sluimer, JD; van der Flier, WM; Verwey, NA	1
Jeong, Y; Lee, MS; Lyoo, CH; Rinne, JO; Ryu, YH	1
Aalto, S; Haaparanta, M; Jokinen, P; Någren, K; Parkkola, R; Rinne, JO; Rokka, J; Röyttä, M; Savisto, N; Scheinin, N	1
Barthel, H; Dukart, J; Horstmann, A; Möller, HE; Mueller, K; Sabri, O; Schroeter, ML; Villringer, A	1
McHugh, PF; Mosconi, L	1
Albin, RL; Bohnen, NI; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S	1
Vallabhajosula, S	1
Lewis, DH; McCue, TJ; Minoshima, S; Toney, LK	1
Choi, KG; Jeong, JH; Kang, HJ; Kim, HS; Kim, JE	1
Barthel, H; Becker, G; Frisch, S; Mueller, K; Sabri, O; Schroeter, ML; Seese, A; Villringer, A; Vogt, B	1
Murray, AD	1
Anzai, Y; Bohnen, NI; Djang, DS; Herholz, K; Minoshima, S	1
DeKosky, ST; Klunk, WE; Lopez, OL; Madeira, C; Mathis, CA; Price, JC; Saxton, JA; Snitz, BE; Wolk, DA	1
Brooks, DJ; Koikkalainen, J; Lötjönen, J; Lundqvist, R; Soininen, H; Thurfjell, L; Vandenberghe, R; Waldemar, G	1
Komatsu, J; Kuwano, R; Matsunari, I; Ono, K; Samuraki, M; Shima, K; Yamada, M; Yanase, D	1
Barrio, JR; Bookheimer, SY; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Siddarth, P; Silverman, DH; Small, GW	1
Arbizu, J; Clavero, P; Garcia-Garcia, D; Gasca Salas, C; Gonzalez-Redondo, R; Lamet, I; Obeso, JA; Rodriguez-Oroz, MC	1
Ataka, S; Kawabe, J; Miki, T; Mizuno, K; Mori, H; Shimada, H; Shiomi, S; Takeuchi, J; Wada, Y; Watanabe, Y	1
Allaoua, M; Assal, F; Gutierrez, D; Lövblad, KO; Montandon, ML; Ratib, O; Zaidi, H	1
Aalten, P; Adriaanse, SF; Handels, RL; Hoekstra, OS; Lammertsma, AA; Lemstra, AW; Ossenkoppele, R; Pijnenburg, YA; Prins, ND; Scheltens, P; van Berckel, BN; van Buchem, MA; van der Flier, WM; Verbeek, MM; Verhey, FR; Windhorst, AD; Wolfs, CA	1
Csepán-Magyar, R; Golüke-Willemse, GA; Rijnders, AJ	1
Chin, J; Jung, DS; Kim, BC; Kim, EJ; Kim, SJ; Lee, KH; Na, DL; Sin, JS; Yoon, YJ	1
Guo, XJ; Li, DC; Ma, AJ; Pan, XD; Zhang, BS	1
Allaoua, M; Assal, F; Burkhard, PR; Garibotto, V; Montandon, ML; Ratib, O; Viaud, CT; Zaidi, H	1
Ishii, K	1
Hashimoto, M; Hirono, N; Ishii, K; Kazui, H; Matsumoto, K; Mori, E; Nakano, Y; Nishio, Y	1
Foster, NL	1
Chang, CY; Chen, W; Cummings, JL; Czernin, J; Kim, SK; Kowell, AP; Phelps, ME; Silverman, DH; Small, GW; Truong, CT	1
Silverman, DH	1
Diehl, J; Drzezga, A; Förstl, H; Grimmer, T; Kurz, A	1
Higashi, K; Hirose, G; Hori, A; Kataoka, S; Matsunari, I; Saiki, M; Saiki, S; Sakai, K; Shimazaki, K	1
Benke, T; Delazer, M; Donnemiller, E; Karner, E; Marksteiner, J; Seppi, K	1
Greenstein, EA; Tikofsky, RS; Van Heertum, RL	1
Hajak, G; Ibach, B; Männer, P; Marienhagen, J; Poljansky, S; Vogel, M	1
Anchisi, D; Fazio, F; Franceschi, M; Matarrese, M; Moresco, RM; Pelati, O; Perani, D; Zuffi, M	1
Cho, SS; Jeong, Y; Kang, E; Kang, SJ; Kim, SE; Lee, JS; Na, DL; Park, JM	1
Cho, SS; Jeong, Y; Kang, E; Kang, SJ; Kim, EJ; Kim, SE; Na, DL; Park, KC	1
Maes, A; Mortelmans, L; Moulin-Romsee, G; Silverman, D; Van Laere, K	1
Baron, JC; Chételat, G; De La Sayette, V; Desgranges, B; Dupuy, B; Eustache, F; Hannequin, D; Mézenge, F; Pélerin, A; Viader, F	1
Döbert, N; Frölich, L; Grünwald, F; Hamscho, N; Menzel, C; Pantel, J	1
Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S	1
Baron, JC; Beuthien-Baumann, B; Collette, F; Degueldre, C; Garraux, G; Herholz, K; Holthoff, V; Kerrouche, N; Lemaire, C; Luxen, A; Perani, D; Salmon, E	1
Bornschein, S; Diehl-Schmid, J; Drzezga, A; Förstl, H; Grimmer, T; Kurz, A; Riemenschneider, M; Schwaiger, M	1
Kassubek, J; Ludolph, AC; Mottaghy, FM; Riecker, A; Schreiber, H; Uttner, I	1
Beuthien-Baumann, B; Collette, F; Degueldre, C; Herholz, K; Holthoff, V; Lemaire, C; Perani, D; Peters, F; Pupi, A; Salmon, E; Sorbi, S	1
Alexopoulos, P; Domes, G; Grimmer, T; Kurz, A; Perneczky, R	1
Small, GW	1
Bornschein, S; Diehl-Schmid, J; Drzezga, A; Forstl, H; Grimmer, T; Kurz, A; Perneczky, R; Schwaiger, M	1
Diehl-Schmid, J; Förstl, H; Kurz, A; Perneczky, R; Pohl, C	1
Arvanitakis, Z; Boeve, BF; Caviness, JN; Cheshire, WP; Dickson, DW; Hutton, ML; Lin, SC; Liss, JM; Pooley, RA; Slowinski, J; Strongosky, AJ; Tsuboi, Y; Uitti, RJ; Witte, RJ; Wszolek, ZK	1
Diehl-Schmid, J; Drzezga, A; Kurz, A; Perneczky, R	1
Boppana, M; de Leon, MJ; De Santi, S; Laska, E; Li, J; Li, Y; Mosconi, L; Rusinek, H; Tsui, WH	1
Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Sakamoto, S; Sofue, K	1
Bartenstein, P; Fellgiebel, A; Hiemke, C; Müller, MJ; Schreckenberger, M	1
Boecker, H; Diehl-Schmid, J; Drzezga, A; Forstl, H; Haussermann, P; Kurz, A; Perneczky, R	1
Neumann, J; Raczka, K; Schroeter, ML; Yves von Cramon, D	1
Diehl-Schmid, J; Drzezga, A; Förstl, H; Kurz, A; Perneczky, R	1
Bartenstein, P; Fellgiebel, A; Müller, MJ; Scheurich, A	1
Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Landeau, B; Matuszewski, V; Mézenge, F; Piolino, P; Viader, F	1
Cannella, M; Ciammola, A; Ciarmiello, A; Gianfrancesco, F; Gradini, R; Martino, T; Simonelli, M; Squitieri, F	1
Arnold, SE; Barbas, NR; Clark, CM; DeCarli, CS; Foster, NL; Heidebrink, JL; Higdon, R; Jagust, WJ; Koeppe, RA; Minoshima, S; Turner, RS	1
Bäuml, J; Diehl-Schmid, J; Drzezga, A; Eisele, T; Förstl, H; Ibach, B; Kurz, A; Laws, SM; Perneczky, R; Riemenschneider, M	1
Ghetti, B; Grafman, J; Huey, ED; Murrell, JR; Pietrini, P; Spina, S; Wassermann, EM	1
Kelly, PJ; Lynch, T; Marnane, M; McKeon, A; O'connell, M; Stack, JP	1
An, YS; Lee, PH; Yong, SW; Yoon, JK	1
DeKosky, S; Diehl-Schmid, J; Drzezga, A; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Price, J; Schwaiger, M; Stangier, I; Wester, HJ	1
Diehl-Schmid, J; Drzezga, A; Förstl, H; Kurz, A; May, F; Perneczky, R	1
Jonker, C; Mulder, JL; Pijnenburg, YA; Scheltens, P; Stevens, M; Uitdehaag, BM; van Swieten, JC	1
Beuthien-Baumann, B; Caselli, R; Clerici, F; de Leon, MJ; Diehl-Schmid, J; Drzezga, A; Herholz, K; Holthoff, V; Kalbe, E; Kurz, A; Lucignani, G; Minoshima, S; Mosconi, L; Perneczky, R; Pupi, A; Reiman, EM; Sorbi, S; Tsui, WH	1
Coslett, HB; Wiener, M	1
Carter, SF; Herholz, K; Jones, M	1
Kuhl, DE; Markham, CH; Metter, EJ; Phelps, ME; Riege, WH; Winter, J	1
Budinger, TF; Derenzo, SE; Friedland, RP; Ganz, E; Huesman, RH; Koss, B; Mathis, CA; Ober, BA; Yano, Y	1
Brooks, RA; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Patronas, NJ	1
Benson, DF; Cummings, JL; Hawkins, RA; Kuhl, DE; Phelps, ME; Tsai, SY	1
Kuhl, DE	1
Kuhl, DE; Metter, EJ; Riege, WH	3
Ingvar, DH	1
Alavi, A; Christman, DR; De Leon, MJ; Farkas, T; Ferris, SH; Fowler, JS; George, AE; Reisberg, B; Reivich, M; Wolf, AP	1
Alavi, A; Christman, D; Dann, R; Farkas, T; Ferris, S; Fowler, J; Greenberg, J; MacGregor, R; Reivich, M; Wolf, A	1
Mayberg, HS	1
Jagust, WJ	1
Heiss, WD; Herholz, K; Ichimiya, A; Kessler, J; Mielke, R; Slansky, I	1
Diederich, N; Heiss, WD; Herholz, K; Karbe, H; Rudolf, J; Staffen, W	1
Carr, CA; Fischman, AJ; González, RG; Growdon, JH; Guimaraes, AR; Halpern, EF; Rosen, BR; Stern, CE	1
Wagner, HN	1
Coleman, RE; Delong, D; Earl, N; Hanson, MW; Hoffman, JM; Paine, S; Welsh, KA	1
Heiss, WD; Kessler, J; Mielke, R; Uhlhaas, S; Zerres, K	1
Hashimoto, M; Hirono, N; Imamura, T; Ishii, K; Kitagaki, H; Mori, E; Sakamoto, S; Sasaki, M; Shimomura, T; Yamaji, S	1
Delbeke, D; Martin, WH; Patton, JA; Sandler, MP	1
Bohnen, NI; Frey, KA; Giordani, B; Kuhl, DE; Minoshima, S	1
Degueldre, C; Franck, G; Garraux, G; Lemaire, C; Salmon, E	1
Bell, JD; Brooks, DJ; Chaudhuri, KR; Cunningham, VJ; Hammers, A; Hu, MT; Koepp, MJ; Labbé, C; Morris, RG; Taylor-Robinson, SD; Turjanski, N	1
Eberling, JL; Ezekiel, F; Jagust, W; Klein, G; O'Neill, J; Reed, B; Schuff, N; Soto, G; Weiner, MW	1
Conti, PS; Keppler, J	1
Maisey, MN; Plowman, PN; Saunders, CA	1
Phelps, ME; Silverman, DH	1
Coleman, RE; Crain, B; Earl, N; Hanson, M; Hoffman, JM; Hulette, C; Welsh-Bohmer, KA	1
Gustin, S; Halsband, U; Heinks, T; Hüll, M; Juengling, FD; Kassubek, J; Schumann, G	1
De Bleecker , J; De Reuck , J; Dierckx, R; Goethals, P; Lemahieu, I; Santens, P; Slegers, G; Strijckmans, K	1
Coleman, RE; Czernin, J; Gambhir, SS; Phelps, ME; Schwimmer, J; Silverman, DH	1
Hosono, T; Kawamura, T; Kurabayashi, M; Maeno, T; Maeno, Y; Nagai, R; Sando, Y; Sato, M; Suga, T; Tajima, S	1
Alavi, A; Alexander, GE; Chang, CY; Chen, W; Clark, CM; Cummings, JL; Czernin, J; de Leon, MJ; Gambhir, SS; Hoffman, JM; Hoh, CK; Jagust, WJ; Kowell, AP; Kung De Aburto, MA; Lu, CS; Mielke, R; Phelps, ME; Pietrini, P; Rapoport, SI; Salmon, E; Schapiro, MB; Silverman, DH; Small, GW; Welsh-Bohmer, KA	1
Goethals, I; Goldman, S; Laloux, P; Maes, A; Salmon, E; Vander Borght, T	1
Goldman, S; Michotte, A; Tugendhaft, P; Zegers de Beyl, D	1
Berecz, R; Degrell, I; Egerházi, A; Glaub, T; Lengyel, Z; Szakáll, S; Trón, L	1
Hirono, N; Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M	1
Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M	1
Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR	1
Adinoff, B; Bisserbe, JC; Eckardt, MJ; Johnson, JL; Martin, PR; Rawlings, RR; Rio, D; Rohrbaugh, JW; Stapleton, JM	1
Hatazawa, J; Itoh, M; Kinomura, S; Matsui, H; Matsuzawa, T; Meguro, K; Ueda, M; Yamada, K; Yamaguchi, T	1
Burrows, GH; Chase, TN; Mohr, E	1
Heiss, WD; Herholz, K; Pawlik, G; Szelies, B; Wienhard, K	1
Ichiya, Y	1
Hatazawa, J; Itoh, M; Matsuzawa, T	1
Frackowiak, RS	1
Friedland, RP	1
Berg, G; Broder, S; Brunetti, A; Cohen, RM; Di Chiro, G; Eddy, J; Finn, RD; Fulham, MJ; Pizzo, PA; Yarchoan, R	1
Calne, DB; Okada, J; Peppard, R	1
Cutler, NR; Davies, P; Haxby, JV; Heston, LL; Schapiro, MB	1
Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M	1
Cutler, NR; Duara, R; Grady, C; Haxby, J; Heston, L; Larson, S; Moore, A; Rapoport, SI; Schlageter, N; Sundaram, M	1
Calne, DB; Harrop, R; Kamo, H; Martin, WR; McGeer, EG; McGeer, PL; Pate, BD	1
Alavi, A; Bais, S; Chawluk, JB; Dann, R; Hurtig, HI; Kushner, MJ; Reivich, M; Zimmerman, RA	1
Apicella, A; Barker, WW; Boothe, T; Chang, JY; Duara, R; Gross-Glenn, K; Loewenstein, D	1
Dhawan, V; Ginos, JZ; Moeller, JR; Navia, BA; Price, RW; Rottenberg, DA; Sidtis, JJ; Strother, SC	1
Hawkins, RA; Kuhl, DE; Metter, EJ; Riege, WH	1

Reviews

52 review(s) available for fluorodeoxyglucose f18 and Dementia

Article	Year
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings. PET clinics, 2022, Volume: 17, Issue:3 Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2022
Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis. BMC neurology, 2023, Oct-24, Volume: 23, Issue:1 Topics: Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spin Labels	2023
Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients. Topics in magnetic resonance imaging : TMRI, 2019, Volume: 28, Issue:6 Topics: Aged; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2019
Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy. The Israel Medical Association journal : IMAJ, 2020, Volume: 22, Issue:3 Topics: Brain; Dementia; Epilepsy; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2020
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders. Seminars in nuclear medicine, 2021, Volume: 51, Issue:3 Topics: Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2021
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of aging, 2017, Volume: 52 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results	2017
Current and future prospects of nuclear medicine in dementia. Rinsho shinkeigaku = Clinical neurology, 2017, 09-30, Volume: 57, Issue:9 Topics: Alzheimer Disease; Amyloidogenic Proteins; Brain; Dementia; Diagnosis, Differential; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed, Single-Photon	2017
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sensitivity and Specificity	2018
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Sensitivity and Specificity	2018
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Alzheimer Disease; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Prospective Studies	2018
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography	2018
PET/CT of Dementia. AJR. American journal of roentgenology, 2018, Volume: 211, Issue:2 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Current Status of Journal of nuclear medicine technology, 2018, Volume: 46, Issue:4 Topics: Brain; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2018
[Big data and artificial intelligence for diagnostic decision support in atypical dementia]. Der Nervenarzt, 2018, Volume: 89, Issue:8 Topics: Artificial Intelligence; Big Data; Dementia; Diagnosis, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography	2018
Clinical and Technical Considerations for Brain PET Imaging for Dementia. Journal of nuclear medicine technology, 2020, Volume: 48, Issue:1 Topics: Amyloid; Biological Transport; Brain; Dementia; Drug Approval; Fluorodeoxyglucose F18; Guidelines as Topic; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; United States; United States Food and Drug Administration	2020
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. Current neurology and neuroscience reports, 2019, 06-29, Volume: 19, Issue:8 Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2019
Role of positron emission tomography/computed tomography in dementia. Radiologic clinics of North America, 2013, Volume: 51, Issue:5 Topics: Contrast Media; Dementia; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroimaging; Radionuclide Imaging; Radiopharmaceuticals	2013
A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review. International journal of geriatric psychiatry, 2014, Volume: 29, Issue:6 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2014
PET radiotracers for molecular imaging in dementia. Current radiopharmaceuticals, 2013, Volume: 6, Issue:4 Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biomarkers; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Synucleins; tau Proteins	2013
Advances in dementia imaging. Seminars in roentgenology, 2014, Volume: 49, Issue:1 Topics: Aged, 80 and over; Brain; Dementia; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2014
Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures. Nuclear medicine communications, 2014, Volume: 35, Issue:11 Topics: Dementia; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Guidance for reading FDG PET scans in dementia patients. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2014, Volume: 58, Issue:4 Topics: Alzheimer Disease; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Software	2014
Brain FDG PET and the diagnosis of dementia. AJR. American journal of roentgenology, 2015, Volume: 204, Issue:1 Topics: Aged; Aged, 80 and over; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2015
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). The Cochrane database of systematic reviews, 2015, Jan-28, Volume: 1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2015
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:10 Topics: Brain; Cognitive Dysfunction; Dementia; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2015
Brain fluorodeoxyglucose (FDG) PET in dementia. Ageing research reviews, 2016, Volume: 30 Topics: Alzheimer Disease; Animals; Dementia; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals	2016
Molecular Imaging and Precision Medicine in Dementia and Movement Disorders. PET clinics, 2017, Volume: 12, Issue:1 Topics: Biomarkers, Tumor; Dementia; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Molecular Targeted Therapy; Movement Disorders; Positron-Emission Tomography; Precision Medicine; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2017
Cerebrospinal fluid: when is it worthwhile to do a lumbar puncture? CNS spectrums, 2008, Volume: 13, Issue:10 Suppl 1 Topics: Alzheimer Disease; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Puncture; tau Proteins; Temporal Lobe	2008
Paraneoplastic neurological syndromes and the role of PET imaging. Oncology, 2010, Volume: 78, Issue:2 Topics: Breast Neoplasms; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Magnetic Resonance Imaging; Ovarian Neoplasms; Paraneoplastic Syndromes; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Tomography, X-Ray Computed	2010
Autopsy as gold standard in FDG-PET studies in dementia. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2010, Volume: 37, Issue:3 Topics: Autopsy; Brain; Databases, Factual; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2010
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:3 Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Brain; Dementia; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals	2011
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. Seminars in nuclear medicine, 2011, Volume: 41, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzothiazoles; Cerebral Cortex; Dementia; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurofibrillary Tangles; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2011
Nuclear medicine imaging in dementia: a practical overview for hospitalists. Hospital practice (1995), 2011, Volume: 39, Issue:3 Topics: Aged; Alzheimer Disease; Amyloid; Dementia; Diagnosis, Computer-Assisted; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Hospitalists; Humans; Lewy Body Disease; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2011
Imaging approaches for dementia. AJNR. American journal of neuroradiology, 2012, Volume: 33, Issue:10 Topics: Brain; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole Body Imaging	2012
Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:1 Topics: Alzheimer Disease; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reference Standards; Safety	2012
Clinical application of positron emission tomography for diagnosis of dementia. Annals of nuclear medicine, 2002, Volume: 16, Issue:8 Topics: Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Health Care Surveys; Humans; Japan; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed	2002
PET studies in dementia. Annals of nuclear medicine, 2003, Volume: 17, Issue:2 Topics: Acetylcholine; Alzheimer Disease; Brain; Dementia; Dopamine; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Multicenter Studies as Topic; Neurotransmitter Agents; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:4 Topics: Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2004
2-deoxy-fluorglucose-positron emission tomography imaging of the brain: current clinical applications with emphasis on the dementias. Seminars in nuclear medicine, 2004, Volume: 34, Issue:4 Topics: Brain; Brain Mapping; Brain Neoplasms; Cerebrovascular Disorders; Craniocerebral Trauma; Dementia; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals	2004
Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease. Journal of geriatric psychiatry and neurology, 2006, Volume: 19, Issue:3 Topics: Aged; Biomarkers; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2006
Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects. NeuroImage, 2007, Jul-01, Volume: 36, Issue:3 Topics: Aged; Algorithms; Atrophy; Brain Mapping; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals	2007
Positron emission tomography imaging in dementia. The British journal of radiology, 2007, Volume: 80 Spec No 2 Topics: Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurotransmitter Agents; Positron-Emission Tomography; Radiopharmaceuticals	2007
FDG PET and differential diagnosis of dementia. Alzheimer disease and associated disorders, 1995,Spring, Volume: 9, Issue:1 Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed	1995
Clinical correlates of PET- and SPECT-identified defects in dementia. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Alzheimer Disease; Brain; Cognition Disorders; Delusions; Dementia; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Severity of Illness Index; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	1994
Functional imaging in dementia: an overview. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Alzheimer Disease; Brain; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1994
A tabulated summary of the FDG PET literature. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:5 Suppl Topics: Bibliometrics; Brain; Coronary Disease; Dementia; Fluorodeoxyglucose F18; Humans; Myocardium; Neoplasms; Radiopharmaceuticals; Seizures; Tissue Survival; Tomography, Emission-Computed	2001
[Use of positron emission tomography in psychiatry]. Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Suppl 3 Topics: Alcoholism; Brain; Dementia; Fluorodeoxyglucose F18; Glucose; Humans; Mental Disorders; Mood Disorders; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed	2002
Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 1991, Volume: 41, Issue:2 ( Pt 1) Topics: Brain Neoplasms; Cognition Disorders; Dementia; Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Oxygen Radioisotopes; Preoperative Care; Seizures; Tomography, Emission-Computed	1991
PET: studies in dementia. Psychiatry research, 1989, Volume: 29, Issue:3 Topics: Blood Glucose; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Receptors, Dopamine; Tomography, Emission-Computed	1989
Positron emission tomography in dementia. Seminars in neurology, 1989, Volume: 9, Issue:4 Topics: Brain; Cerebrovascular Circulation; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1989
NIH Conference. Alzheimer's disease and Down's syndrome: new insights. Annals of internal medicine, 1985, Volume: 103, Issue:4 Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain; Brain Chemistry; Cognition; Dementia; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neurotransmitter Agents; Parasympathetic Nervous System; Psychological Tests; Tomography, Emission-Computed	1985
Positron emission tomography imaging of regional cerebral glucose metabolism. Seminars in nuclear medicine, 1986, Volume: 16, Issue:1 Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed	1986

Trials

11 trial(s) available for fluorodeoxyglucose f18 and Dementia

Article	Year
Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET. Clinical nuclear medicine, 2020, Volume: 45, Issue:1 Topics: Aged; Amyloid; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Prospective Studies; Stilbenes; Time Factors	2020
Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia - A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management. PloS one, 2019, Volume: 14, Issue:5 Topics: Adolescent; Adult; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2019
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PloS one, 2014, Volume: 9, Issue:3 Topics: Aged; Brain; Dementia; Estrogen Replacement Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Postmenopause; Progestins; Prospective Studies; Risk; Time Factors	2014
Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Experimental gerontology, 2017, Volume: 87, Issue:Pt A Topics: Aged; Aged, 80 and over; California; Cerebral Cortex; Cognition; Cognitive Dysfunction; Dementia; Double-Blind Method; Female; Fluorodeoxyglucose F18; Fruit; Humans; Male; Neuropsychological Tests; Phytotherapy; Pilot Projects; Plant Preparations; Positron-Emission Tomography; Prospective Studies; Vitis	2017
Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:12 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Cholinesterase Inhibitors; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome	2008
Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2013, Volume: 9, Issue:4 Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; France; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Memory Disorders; Middle Aged; Molecular Imaging; Outpatient Clinics, Hospital; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles; Treatment Outcome	2013
Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study. Dementia and geriatric cognitive disorders, 2004, Volume: 18, Issue:1 Topics: Brain Chemistry; Cognition; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed	2004
18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:2 Topics: Adult; Aged; Algorithms; Brain; Data Interpretation, Statistical; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2005
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiology of aging, 2007, Volume: 28, Issue:1 Topics: Aging; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2007
Interpretation variability of 18FDG-positron emission tomography studies in dementia. Investigative radiology, 1996, Volume: 31, Issue:6 Topics: Adult; Aged; Dementia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Tomography, Emission-Computed	1996
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Journal of the neurological sciences, 2002, Jul-15, Volume: 199, Issue:1-2 Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	2002

Other Studies

193 other study(ies) available for fluorodeoxyglucose f18 and Dementia

Article	Year
Predicting cognitive decline in Parkinson's disease using FDG-PET-based supervised learning. The Journal of clinical investigation, 2022, 10-17, Volume: 132, Issue:20 Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Retrospective Studies; Supervised Machine Learning	2022
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:11 Topics: Cerebrovascular Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2020
Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia. Dementia and geriatric cognitive disorders, 2019, Volume: 48, Issue:5-6 Topics: Aged; Aphasia, Primary Progressive; Brain; Dementia; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Evaluating 2-[ NeuroImage. Clinical, 2020, Volume: 27 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon	2020
AI-driven attenuation correction for brain PET/MRI: Clinical evaluation of a dementia cohort and importance of the training group size. NeuroImage, 2020, 11-15, Volume: 222 Topics: Adult; Bone and Bones; Brain; Cohort Studies; Dementia; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Neural Networks, Computer; Positron-Emission Tomography	2020
Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study. Neurology, 2020, 11-17, Volume: 95, Issue:20 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Connectome; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Language; Male; Neurodegenerative Diseases; Occipital Lobe; Pattern Recognition, Visual; Positron-Emission Tomography; Retrospective Studies; Semantics; Speech; Supranuclear Palsy, Progressive; Temporal Lobe	2020
Biomarkers for dementia: too soon for routine clinical use. The Lancet. Neurology, 2020, Volume: 19, Issue:11 Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Dementia; Fluorodeoxyglucose F18; Humans	2020
Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Patient Care Management; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2020
FDG PET/MRI for Visual Detection of Crossed Cerebellar Diaschisis in Patients With Dementia. AJR. American journal of roentgenology, 2021, Volume: 216, Issue:1 Topics: Aged; Cerebellum; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
A Pioneering Paper That Provided a Tool for Accurate, Observer-Independent Analysis of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:Suppl 2 Topics: Brain; Dementia; Fluorodeoxyglucose F18; Humans; Publications; Sensitivity and Specificity	2020
Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods. Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:2 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Machine Learning; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2021
Clinical Relevance of [ Molecules (Basel, Switzerland), 2021, Feb-26, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; tau Proteins	2021
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular psychiatry, 2018, Volume: 23, Issue:7 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; tau Proteins	2018
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's disease : JAD, 2017, Volume: 59, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Thiazoles	2017
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:13 Topics: Amyloid; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography	2017
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:3 Topics: Aged; Aged, 80 and over; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Thiazoles	2017
"Occipital Tunnel" Sign on FDG PET for Differentiating Dementias. Clinical nuclear medicine, 2018, Volume: 43, Issue:2 Topics: Biological Transport; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Occipital Lobe; Positron-Emission Tomography	2018
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology, 2018, 03-13, Volume: 90, Issue:11 Topics: Aged; Agnosia; Amyloid; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Prognosis; Radiopharmaceuticals	2018
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology, 2018, 03-20, Volume: 90, Issue:12 Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity	2018
MR-assisted PET motion correction in simultaneous PET/MRI studies of dementia subjects. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 48, Issue:5 Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Brain; Dementia; Female; Fluorodeoxyglucose F18; Head Movements; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Normal Distribution; Positron-Emission Tomography	2018
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain : a journal of neurology, 2018, 04-01, Volume: 141, Issue:4 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Cohort Studies; Dementia; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Sclerosis; tau Proteins; Thiazoles	2018
Measures of metabolism provide insights into hippocampal sclerosis. Brain : a journal of neurology, 2018, 04-01, Volume: 141, Issue:4 Topics: Autopsy; Dementia; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Hippocampus; Humans; Sclerosis	2018
Biomarkers study in atypical dementia: proof of a diagnostic work-up. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2018, Volume: 39, Issue:7 Topics: Aged; Amyloid beta-Peptides; Biomarkers; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; tau Proteins	2018
Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia. Clinical nuclear medicine, 2018, Volume: 43, Issue:6 Topics: Algorithms; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2018
Does Integrated PET/MR Have a Role in the Management of Patients with Dementia? Radiology, 2018, Volume: 288, Issue:1 Topics: Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography	2018
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain European journal of neurology, 2018, Volume: 25, Issue:10 Topics: Brain; Cognitive Dysfunction; Consensus; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity	2018
Amyloid involvement in subcortical regions predicts cognitive decline. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13 Topics: Aged; Amyloid; Brain; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Prognosis	2018
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in Human brain mapping, 2018, Volume: 39, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Attention; Cognitive Dysfunction; Dementia; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography	2018
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [ European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:2 Topics: Aged; Amyloid; Area Under Curve; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography	2019
Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study. Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:3 Topics: Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mental Disorders; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stilbenes	2018
Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia. Cytotherapy, 2019, Volume: 21, Issue:4 Topics: Aged; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Injections, Spinal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Positron-Emission Tomography; Transplantation, Autologous	2019
Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Annals of clinical and translational neurology, 2019, Volume: 6, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2019
Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India. Asian journal of psychiatry, 2019, Volume: 44 Topics: Adult; Aged; Biomarkers; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; India; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2019
Voxel-based classification of FDG PET in dementia using inter-scanner normalization. NeuroImage, 2013, Aug-15, Volume: 77 Topics: Aged; Artificial Intelligence; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2013
Frontal network syndrome testing: clinical tests and positron emission tomography brain imaging help distinguish the 3 most common dementia subtypes. American journal of Alzheimer's disease and other dementias, 2013, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Middle Aged; Nerve Net; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography	2013
The Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data. International journal of stroke : official journal of the International Stroke Society, 2014, Volume: 9, Issue:3 Topics: Aged; Amyloid; Ankle Brachial Index; Carotid Intima-Media Thickness; Cohort Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurologic Examination; Neuropsychological Tests; Pilot Projects; Positron-Emission Tomography; Retina; Stroke; Treatment Outcome; Waist-Hip Ratio	2014
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology, 2013, Oct-08, Volume: 81, Issue:15 Topics: Adult; Aged; Brain Mapping; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Progranulins; Retrospective Studies	2013
Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT. The neuroradiology journal, 2014, Volume: 27, Issue:1 Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed	2014
Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study. Neurologia (Barcelona, Spain), 2015, Volume: 30, Issue:3 Topics: Adult; Aged; Brain; Creutzfeldt-Jakob Syndrome; Dementia; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Insomnia, Fatal Familial; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2015
Automated identification of dementia using FDG-PET imaging. BioMed research international, 2014, Volume: 2014 Topics: Algorithms; Artificial Intelligence; Automation; Databases as Topic; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2014
Lyme neuroborreliosis and dementia. Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Lyme Neuroborreliosis; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2014
Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:6 Topics: Adult; Aged; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2014
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 8 Topics: Aged; Aged, 80 and over; Atrophy; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index	2014
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics, 2014, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity	2014
Management impact of FDG-PET in dementia: results from a tertiary center memory clinic. Journal of Alzheimer's disease : JAD, 2014, Volume: 42, Issue:3 Topics: Aged; Aged, 80 and over; Aphasia; Brain; Chi-Square Distribution; Dementia; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Tertiary Care Centers	2014
Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT. Annals of nuclear medicine, 2015, Volume: 29, Issue:3 Topics: Aged; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Frail Elderly; Humans; Male; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed	2015
Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clinical nuclear medicine, 2015, Volume: 40, Issue:4 Topics: Aged; Autoimmune Diseases; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Incidental Findings; Limbic Encephalitis; Male; Positron-Emission Tomography; Radiopharmaceuticals	2015
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. NeuroImage. Clinical, 2015, Volume: 7 Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals	2015
Optimal likelihood-ratio multiple testing with application to Alzheimer's disease and questionable dementia. BMC medical research methodology, 2015, Jan-30, Volume: 15 Topics: Alzheimer Disease; Brain; Computer Simulation; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Likelihood Functions; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity	2015
MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3 Topics: Aged; Algorithms; Artifacts; Automation; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Software	2015
Pareidolia in Parkinson's disease without dementia: A positron emission tomography study. Parkinsonism & related disorders, 2015, Volume: 21, Issue:6 Topics: Aged; Dementia; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Hallucinations; Humans; Illusions; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Parkinson Disease; Photic Stimulation; Positron-Emission Tomography; Temporal Lobe	2015
Topography of primitive reflexes in dementia: an F-18 fluorodeoxyglucose positron emission tomography study. European journal of neurology, 2015, Volume: 22, Issue:8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Prospective Studies; Putamen; Reflex; Thalamus	2015
Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders. Molecular neurobiology, 2016, Volume: 53, Issue:7 Topics: Aged; Dementia; Demography; Female; Fluorodeoxyglucose F18; Humans; Linkage Disequilibrium; Male; Neuroimaging; Phenotype; Phospholipase D; Polymorphism, Single Nucleotide; Positron-Emission Tomography	2016
18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results	2015
FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia. European archives of psychiatry and clinical neuroscience, 2016, Volume: 266, Issue:6 Topics: Adult; Aged; Analysis of Variance; Brain; Case-Control Studies; Catatonia; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Schizophrenia; Serial Learning	2016
Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes. Journal of Alzheimer's disease : JAD, 2016, Volume: 49, Issue:3 Topics: Adult; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2016
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles	2016
Metabolic connectivity for differential diagnosis of dementing disorders. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:1 Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Metabolic Networks and Pathways; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe	2017
The value of FDG-PET/CT by using 3-dimensional stereotactic surface projection software analysis in the differential diagnosis of dementia. Turkish journal of medical sciences, 2015, Volume: 45, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Software; Stereotaxic Techniques; Tomography, X-Ray Computed	2015
[Acceptance of dementia diagnostics by getriatric hospital patients : Comparison of various investigation methods with emphasis on FDG-PET imaging]. Zeitschrift fur Gerontologie und Geriatrie, 2017, Volume: 50, Issue:1 Topics: Aged, 80 and over; Attitude to Health; Dementia; Female; Fluorodeoxyglucose F18; Germany; Hospitalization; Humans; Male; Neuropsychological Tests; Patient Acceptance of Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Factors	2017
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease. PloS one, 2016, Volume: 11, Issue:4 Topics: Aged; Brain; Cerebral Cortex; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2016
Amyloid imaging for dementia in Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, May-17, Volume: 188, Issue:8 Topics: Amyloid; Canada; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2016
Preserved brain metabolic activity at the age of 96 years. International psychogeriatrics, 2016, Volume: 28, Issue:9 Topics: Aged, 80 and over; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2016
Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong. Hong Kong medical journal = Xianggang yi xue za zhi, 2016, Volume: 22, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thiazoles	2016
Delayed-onset dementia after stroke or transient ischemic attack. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2016, Volume: 12, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Apolipoproteins E; Brain; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Phenanthrolines; Positron-Emission Tomography; Prospective Studies; Stroke; Thiazoles; Time Factors; Tomography, X-Ray Computed; Young Adult	2016
The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia. Journal of Alzheimer's disease : JAD, 2017, Volume: 55, Issue:1 Topics: Aged; Aphasia, Primary Progressive; Brain; Cognition; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Retrospective Studies	2017
Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia. Medicine, 2016, Volume: 95, Issue:49 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Body Disease; Positron-Emission Tomography; Republic of Korea; Retrospective Studies; ROC Curve	2016
Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease. Journal of the neurological sciences, 2017, Jan-15, Volume: 372 Topics: Aged; Aged, 80 and over; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index	2017
Independent value added by diffusion MRI for prediction of cognitive function in older adults. NeuroImage. Clinical, 2017, Volume: 14 Topics: Aged; Aged, 80 and over; Aging; Amyloid beta-Peptides; Cognitive Dysfunction; Dementia; Diffusion Magnetic Resonance Imaging; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Principal Component Analysis; Regression Analysis	2017
Boosting brain glucose metabolism to fight neurodegeneration? Oncotarget, 2017, Feb-28, Volume: 8, Issue:9 Topics: Amyloid beta-Peptides; Animals; Arachidonic Acids; Brain; Cyclooxygenase 2; Dementia; Endocannabinoids; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Insulin; Ligands; Mice; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Polyunsaturated Alkamides; Positron-Emission Tomography; Protein Folding; Receptor, Cannabinoid, CB2; Signal Transduction	2017
Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:12 Topics: Aged; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography	2008
Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease. Archives of neurology, 2008, Volume: 65, Issue:10 Topics: 14-3-3 Proteins; Akinetic Mutism; Brain; Codon; Creutzfeldt-Jakob Syndrome; Dementia; Disease Progression; DNA Mutational Analysis; Electroencephalography; Fatal Outcome; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Heterozygote; Humans; Magnetic Resonance Imaging; Middle Aged; Mutation, Missense; Neuropsychological Tests; Polymorphism, Genetic; Positron-Emission Tomography; Prions; Radiography; Radiopharmaceuticals	2008
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Annals of neurology, 2008, Volume: 64, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Aniline Compounds; Aphasia, Primary Progressive; Carbon Isotopes; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Language; Language Tests; Male; Middle Aged; Positron-Emission Tomography; Thiazoles	2008
A novel insertional mutation in the prion protein gene: clinical and bio-molecular findings. Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:12 Topics: Adult; Brain; Cloning, Molecular; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Models, Genetic; Mutation; Neurodegenerative Diseases; Prion Proteins; Prions; Radiopharmaceuticals; Recombinant Proteins	2008
[SPECT and FDG-PET in diagnostics of neurolues]. Wiener klinische Wochenschrift, 2008, Volume: 120, Issue:19-20 Supp Topics: Adult; Basal Ganglia; Blood Glucose; Brain; Cysteine; Dementia; Diagnosis, Differential; Diseases in Twins; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neurosyphilis; Organotechnetium Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Syphilis, Cardiovascular; Syphilis, Congenital; Tomography, Emission-Computed, Single-Photon	2008
Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2008, Volume: 2008 Topics: Algorithms; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2008
The underlying mechanisms of verbal fluency deficit in frontotemporal dementia and semantic dementia. Journal of neurology, 2009, Volume: 256, Issue:7 Topics: Aged; Brain Mapping; Dementia; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Language Tests; Male; Memory; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Speech; Speech Disorders; Temporal Lobe; Verbal Behavior	2009
Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Blood Glucose; Brain; Cognition; Dementia; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis	2009
Occurrence of basal ganglia germ cell tumors without a mass. Archives of neurology, 2009, Volume: 66, Issue:6 Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Agents; Asian People; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Calcinosis; Child; Dementia; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Paresis; Positron-Emission Tomography; Radiotherapy	2009
Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC neurology, 2009, Aug-12, Volume: 9 Topics: Adult; Aged; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies	2009
Construction of a (18)F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients. International journal of geriatric psychiatry, 2010, Volume: 25, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cognition Disorders; Databases, Factual; Dementia; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals	2010
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. NeuroImage, 2010, Jan-15, Volume: 49, Issue:2 Topics: Age Factors; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cerebellum; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Glucose; Humans; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted	2010
Acute toxicity of two Alzheimer's disease radiopharmaceuticals: FDDNP and IMPY. Drug and chemical toxicology, 2009, Volume: 32, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Dementia; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Neurodegenerative Diseases; Neurofibrillary Tangles; Pyrazoles; Radiopharmaceuticals; Tissue Distribution	2009
MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Current Alzheimer research, 2010, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Brain Mapping; Cognition Disorders; Dementia; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Memory Disorders; Positron-Emission Tomography; Predictive Value of Tests; Prognosis	2010
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis. NeuroImage, 2010, Apr-15, Volume: 50, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain; Computer Simulation; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Models, Statistical; Neurodegenerative Diseases; Positron-Emission Tomography; ROC Curve; Signal Processing, Computer-Assisted	2010
White matter integrity and cortical metabolic associations in aging and dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2010, Volume: 6, Issue:1 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cerebrovascular Disorders; Cohort Studies; Corpus Callosum; Dementia; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies	2010
Reversible alcohol-related dementia: a five-year follow-up study using FDG-PET and neuropsychological tests. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:4 Topics: Adult; Alcoholism; Dementia; Diencephalon; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Korsakoff Syndrome; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Prosencephalon; Radiopharmaceuticals; Temperance	2010
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of neurology, 2010, Volume: 67, Issue:4 Topics: Age of Onset; Aged; Aged, 80 and over; Binding, Competitive; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition Disorders; Dementia; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tetrabenazine	2010
The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study. American journal of Alzheimer's disease and other dementias, 2010, Volume: 25, Issue:4 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies	2010
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dementia and geriatric cognitive disorders, 2010, Volume: 30, Issue:1 Topics: Aged; Alzheimer Disease; Ambulatory Care Facilities; Amyloid beta-Peptides; Cognition Disorders; Data Interpretation, Statistical; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychometrics; Reproducibility of Results; tau Proteins	2010
Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. European neurology, 2010, Volume: 64, Issue:2 Topics: Aged; Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2010
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia. Parkinsonism & related disorders, 2010, Volume: 16, Issue:10 Topics: Aged; Aged, 80 and over; Aniline Compounds; Atrophy; Benzothiazoles; Cerebellum; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2010
Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PloS one, 2011, Mar-23, Volume: 6, Issue:3 Topics: Algorithms; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2011
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6 Topics: Adult; Aged; Brain Chemistry; Cerebral Cortex; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2011
Diffuse cortical hypometabolism on (18)F-FDG-PET scan in a case of an adult variant cerebello-brainstem dominant form of ALD manifesting dementia. Parkinsonism & related disorders, 2012, Volume: 18, Issue:2 Topics: Adrenoleukodystrophy; Adult; Brain Stem; Cerebellum; Cerebral Cortex; Dementia; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography	2012
Dissociating behavioral disorders in early dementia-An FDG-PET study. Psychiatry research, 2011, Dec-30, Volume: 194, Issue:3 Topics: Aged; Analysis of Variance; Behavioral Symptoms; Brain; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Regression Analysis	2011
Amyloid imaging in dementias with atypical presentation. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2012, Volume: 8, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amyloid; Aniline Compounds; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2012
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neuro-degenerative diseases, 2012, Volume: 10, Issue:1-4 Topics: Adult; Aged; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2012
Imaging findings of familial dementia with a tau R406W mutation. Acta neurologica Belgica, 2011, Volume: 111, Issue:4 Topics: Aged; Aniline Compounds; Arginine; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mutation; Positron-Emission Tomography; tau Proteins; Thiazoles; Tryptophan	2011
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:10 Topics: Aged; Aged, 80 and over; Cerebellum; Cluster Analysis; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Risk Factors	2012
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:11 Topics: Aged; Case-Control Studies; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Clinical features of Pittsburgh compound-B-negative dementia. Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles	2012
Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2012, Volume: 36, Issue:8 Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique	2012
[18 FDG PET imaging of the brain in the analysis of a dementia syndrome]. Tijdschrift voor gerontologie en geriatrie, 2012, Volume: 43, Issue:5 Topics: Aged; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Humans; Middle Aged; Positron-Emission Tomography	2012
Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR. Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6 Topics: Age of Onset; Aged; Brain Chemistry; Brain Mapping; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis	2012
[A study on the cerebral glucose metabolism in progressive supranuclear palsy]. Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:11 Topics: Aged; Brain; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive	2012
Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia. Clinical nuclear medicine, 2013, Volume: 38, Issue:3 Topics: Aged; Aged, 80 and over; Biological Transport; Dementia; Discriminant Analysis; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2013
Striatal infarcts mimicking frontotemporal dementia: a case report. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Aged; Brain Infarction; Corpus Striatum; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Radiography; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2003
Validating FDG-PET as a biomarker for frontotemporal dementia. Experimental neurology, 2003, Volume: 184 Suppl 1 Topics: Biomarkers; Brain Mapping; Dementia; Fluorodeoxyglucose F18; Humans; Reproducibility of Results; Tomography, Emission-Computed	2003
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molecular genetics and metabolism, 2003, Volume: 80, Issue:3 Topics: Aged; Brain; Dementia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed	2003
Chorea-acanthocytosis associated with Tourettism. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Chorea; Corpus Striatum; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Radiopharmaceuticals; Speech Disorders; Tomography, Emission-Computed; Tourette Syndrome	2004
Subacute dementia and imaging correlates in a case of Fahr's disease. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:8 Topics: Aggression; Anxiety; Basal Ganglia Diseases; Calcinosis; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Social Behavior; Syndrome; Tomography, Emission-Computed	2004
[Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease]. Psychiatrische Praxis, 2004, Volume: 31 Suppl 1 Topics: Aged; Alzheimer Disease; Blood Glucose; Cerebral Cortex; Dementia; Diagnosis, Differential; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Values	2004
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Annals of neurology, 2005, Volume: 57, Issue:2 Topics: Aged; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Neuropsychological Tests; Positron-Emission Tomography; Receptors, Serotonin	2005
Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology, 2005, Feb-22, Volume: 64, Issue:4 Topics: Aged; Bulbar Palsy, Progressive; Cerebellum; Cerebral Cortex; Dementia; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Motor Neuron Disease; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe	2005
Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective. European journal of neurology, 2005, Volume: 12, Issue:4 Topics: Algorithms; Case-Control Studies; Cost-Benefit Analysis; Dementia; Europe; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity	2005
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase, 2005, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Analysis of Variance; Brain Concussion; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Memory; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Regression, Psychology; Reproducibility of Results; Time Factors	2005
Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index. Dementia and geriatric cognitive disorders, 2005, Volume: 20, Issue:2-3 Topics: Aged; Brain; Brain Chemistry; Cerebrovascular Circulation; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon	2005
11C-DTBZ and 18F-FDG PET measures in differentiating dementias. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine	2005
Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. NeuroImage, 2006, Apr-15, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies	2006
Primary progressive aphasia accompanied by environmental sound agnosia: a neuropsychological, MRI and PET study. Psychiatry research, 2006, Mar-31, Volume: 146, Issue:2 Topics: Aged; Aphasia; Auditory Perceptual Disorders; Brain; Dementia; Disease Progression; Environment; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Severity of Illness Index	2006
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia and geriatric cognitive disorders, 2006, Volume: 21, Issue:5-6 Topics: Aged; Cognition Disorders; Dementia; Depression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Inhibition, Psychological; Male; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Temporal Lobe	2006
Progression to dementia in clinical subtypes of mild cognitive impairment. Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:1 Topics: Aged; Amnesia; Brain Chemistry; Cognition Disorders; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2006
Longitudinal changes of cerebral glucose metabolism in semantic dementia. Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:4 Topics: Age of Onset; Brain Chemistry; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals; Semantics	2006
Behavioral disturbances in the course of frontotemporal dementia. Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:4 Topics: Age of Onset; Aged; Dementia; Feeding and Eating Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals	2006
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism & related disorders, 2007, Volume: 13, Issue:4 Topics: Adult; Asparagine; Cerebral Cortex; Chromosomes, Human, Pair 17; Dementia; Family Health; Female; Fluorodeoxyglucose F18; Humans; Lysine; Male; Middle Aged; Mutation; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; tau Proteins	2007
Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:7 Topics: Aged; Brain; Dementia; Educational Status; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2007
Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiology of aging, 2008, Volume: 29, Issue:5 Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Hippocampus; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic	2008
Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:9 Topics: Aged; Alzheimer Disease; Automation; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Bodies; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Reproducibility of Results; ROC Curve	2007
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2007, Volume: 8, Issue:2 Topics: Aged; Antipsychotic Agents; Aripiprazole; Blood Glucose; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Male; Mental Status Schedule; Piperazines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2007
Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6 Topics: Aged; Blood Glucose; Brain; Brain Mapping; Case-Control Studies; Dementia; Educational Status; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recruitment, Neurophysiological	2007
Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:11 Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Radiopharmaceuticals; Sex Characteristics	2007
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment. Psychiatry research, 2007, Jul-15, Volume: 155, Issue:2 Topics: Aged; Biomarkers; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Longitudinal Studies; Male; Mental Status Schedule; Positron-Emission Tomography; Prognosis; Psychiatric Status Rating Scales; Severity of Illness Index; Stereotaxic Techniques; tau Proteins	2007
In search of autobiographical memories: A PET study in the frontal variant of frontotemporal dementia. Neuropsychologia, 2007, Sep-20, Volume: 45, Issue:12 Topics: Aged; Aged, 80 and over; Amnesia; Brain Mapping; Cognition; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals; Self Concept	2007
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia. Journal of neurology, neurosurgery, and psychiatry, 2007, Volume: 78, Issue:12 Topics: Adult; Brain; Codon; Dementia; DNA Repeat Expansion; Early Diagnosis; Fluorodeoxyglucose F18; Genotype; Humans; Italy; Magnetic Resonance Imaging; Male; Pedigree; Point Mutation; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prion Proteins; Prions; Radiopharmaceuticals	2007
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 10 Topics: Adult; Aged; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2007
Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. The American journal of psychiatry, 2007, Volume: 164, Issue:10 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cerebral Cortex; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucose; Haplotypes; Humans; Male; Middle Aged; Positron-Emission Tomography; Risk Factors; tau Proteins; Tauopathies	2007
Corticobasal syndrome associated with the A9D Progranulin mutation. Journal of neuropathology and experimental neurology, 2007, Volume: 66, Issue:10 Topics: Alleles; Apraxias; Brain; Cognition Disorders; Dementia; DNA; DNA-Binding Proteins; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Progranulins; Reverse Transcriptase Polymerase Chain Reaction; Syndrome	2007
Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Archives of neurology, 2007, Volume: 64, Issue:10 Topics: Aged, 80 and over; Anti-Inflammatory Agents; Autoantibodies; Brain Damage, Chronic; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Potassium Channels, Voltage-Gated; Prednisolone; Radiopharmaceuticals	2007
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. European journal of neurology, 2007, Volume: 14, Issue:12 Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity	2007
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. NeuroImage, 2008, Jan-15, Volume: 39, Issue:2 Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Brain Chemistry; Dementia; Female; Fluorodeoxyglucose F18; Functional Laterality; Genotype; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2008
Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:3 Topics: Aged; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Urinary Incontinence	2008
Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population. Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:2 Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Brain; Cognition Disorders; Consensus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Patient Care Team; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon	2008
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Dementia; Europe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; United States	2008
Disruption of temporal processing in a subject with probable frontotemporal dementia. Neuropsychologia, 2008, Volume: 46, Issue:7 Topics: Attention; Auditory Perception; Biological Clocks; Cognition Disorders; Control Groups; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Judgment; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Reaction Time; Temporal Lobe; Time Perception; Visual Perception	2008
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Annals of neurology, 1982, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Atrophy; Blood Glucose; Brain; Caudate Nucleus; Cerebral Cortex; Cerebral Ventricles; Child; Corpus Striatum; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Putamen; Thalamus; Tomography, Emission-Computed; Tomography, X-Ray Computed	1982
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. Journal of computer assisted tomography, 1983, Volume: 7, Issue:4 Topics: Aged; Alzheimer Disease; Cerebral Cortex; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed	1983
Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology, 1983, Volume: 33, Issue:8 Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Tomography, Emission-Computed	1983
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Archives of neurology, 1983, Volume: 40, Issue:12 Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed	1983
Imaging local brain function with emission computed tomography. Radiology, 1984, Volume: 150, Issue:3 Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain; Cerebrovascular Disorders; Child, Preschool; Dementia; Deoxyglucose; Depressive Disorder; Epilepsy; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed	1984
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Annals of neurology, 1984, Volume: 15, Issue:5 Topics: Aged; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	1984
Measurements of regional cerebral blood flow and metabolism in psychopathological states. European neurology, 1981, Volume: 20, Issue:3 Topics: Cerebrovascular Circulation; Chronic Disease; Dementia; Deoxyglucose; Epilepsies, Partial; Fluorodeoxyglucose F18; Glucose; Humans; Schizophrenia; Tomography, Emission-Computed	1981
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. The American journal of psychiatry, 1982, Volume: 139, Issue:3 Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Tomography, Emission-Computed	1982
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. Experimental brain research, 1982, Volume: Suppl 5 Topics: Adult; Age Factors; Aged; Auditory Cortex; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Reference Values; Tomography, Emission-Computed; Visual Cortex	1982
Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study. Journal of the neurological sciences, 1994, Volume: 123, Issue:1-2 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebellum; Cerebral Cortex; Dementia; Deoxyglucose; Factor Analysis, Statistical; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Organ Specificity; Tomography, Emission-Computed	1994
[Functional significance of calcinosis of the basal ganglia via positron emission tomography]. Fortschritte der Neurologie-Psychiatrie, 1994, Volume: 62, Issue:4 Topics: Adult; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Brain; Calcinosis; Dementia; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologic Examination; Tomography, Emission-Computed	1994
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Volume; Brain; Cerebrovascular Circulation; Dementia; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, Emission-Computed	1995
1996 SNM annual meeting: medical problem solving. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:8 Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1996
Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neuroscience letters, 1998, Sep-18, Volume: 254, Issue:1 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Basal Ganglia; Brain Stem; Cerebellum; Cerebral Cortex; Dementia; DNA; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Gene Frequency; Genotype; Heterozygote; Homozygote; Humans; Intelligence Tests; Leukocytes; Linear Models; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Temporal Lobe; Tomography, Emission-Computed	1998
Cerebral glucose metabolism in patients with frontotemporal dementia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:11 Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Dementia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed	1998
FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:1 Topics: Adult; Aged; Brain; Brain Diseases; Dementia; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	1999
Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology, 1999, Volume: 52, Issue:3 Topics: Aged; Brain Mapping; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Tomography, Emission-Computed	1999
Medial temporal lobe metabolic impairment in dementia associated with motor neuron disease. Journal of the neurological sciences, 1999, Oct-15, Volume: 168, Issue:2 Topics: Aged; Amygdala; Dementia; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Hippocampus; Humans; Male; Middle Aged; Motor Neuron Disease; Parahippocampal Gyrus; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed	1999
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain : a journal of neurology, 2000, Volume: 123 ( Pt 2) Topics: Aged; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucagon; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphorus Isotopes; Temporal Lobe; Tomography, Emission-Computed	2000
Method to correlate 1H MRSI and 18FDG-PET. Magnetic resonance in medicine, 2000, Volume: 43, Issue:2 Topics: Aged; Algorithms; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed	2000
New indications give PET a lift after struggle over regulatory and reimbursement issues. Diagnostic imaging, 2000, Volume: 22, Issue:1 Topics: Dementia; Fluorodeoxyglucose F18; Health Services Accessibility; Humans; Insurance, Health, Reimbursement; Mobile Health Units; Neoplasms; Nuclear Medicine Department, Hospital; Radiopharmaceuticals; Tomography, Emission-Computed; United States; United States Food and Drug Administration	2000
Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan. British journal of neurosurgery, 1998, Volume: 12, Issue:3 Topics: Adult; Blood Glucose; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Child; Dementia; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Neuroepithelial; Tomography, Emission-Computed	1998
Evaluating dementia using PET: how do we put into clinical perspective what we know to date? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:11 Topics: Alzheimer Disease; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2000
FDG PET imaging in patients with pathologically verified dementia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:11 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed	2000
Combined semantic dementia and apraxia in a patient with frontotemporal lobar degeneration. Psychiatry research, 2000, Nov-20, Volume: 100, Issue:1 Topics: Anomia; Apraxias; Atrophy; Dementia; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Pick Disease of the Brain; Semantics; Temporal Lobe; Tomography, Emission-Computed	2000
Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis. European neurology, 2001, Volume: 45, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Temporal Lobe; Tomography, Emission-Computed	2001
Pulmonary intravascular lymphoma complicated with Pneumocystis carinii pneumonia: a case report. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:7 Topics: Aged; Dementia; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Pneumocystis; Radionuclide Imaging; Vascular Neoplasms	2001
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA, 2001, Nov-07, Volume: 286, Issue:17 Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Likelihood Functions; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicin Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Acetazolamide; Adult; Brain; Brain Death; Cerebrovascular Disorders; Child; Craniocerebral Trauma; Dementia; Diagnosis, Differential; Epilepsy; Fasting; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Parkinson Disease; Radiopharmaceuticals; Subarachnoid Hemorrhage; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2001
Frontotemporal dementia: a clinical-pathological study. Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Adult; Aphasia; Atrophy; Cell Count; Dementia; Fatal Outcome; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gliosis; Humans; Mental Disorders; Neurons; Personality Disorders; tau Proteins; Temporal Lobe; Tomography, Emission-Computed; Ubiquitin	2001
Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia. Annals of nuclear medicine, 1992, Volume: 6, Issue:4 Topics: Aged; Brain; Dementia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	1992
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. The Journal of neuropsychiatry and clinical neurosciences, 1992,Summer, Volume: 4, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1992
Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism. The Journal of neuropsychiatry and clinical neurosciences, 1992,Spring, Volume: 4, Issue:2 Topics: Aged; Alcohol Amnestic Disorder; Alcoholism; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Dementia; Deoxyglucose; Dominance, Cerebral; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Substance-Related Disorders; Tomography, Emission-Computed; Wernicke Encephalopathy	1992
Characteristics of cerebral glucose utilization in dementia. The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku, 1990, Volume: 37, Issue:1-4 Topics: Aged; Alzheimer Disease; Brain; Cerebral Infarction; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Reference Values; Tomography, Emission-Computed	1990
Brain glucose metabolism in Parkinson's disease. Advances in neurology, 1990, Volume: 53 Topics: Aged; Blood Glucose; Brain; Brain Mapping; Dementia; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed	1990
Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type. Archives of gerontology and geriatrics, 1987, Volume: 6, Issue:3 Topics: Aged; Aphasia; Brain; Dementia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Personality Disorders; Tomography, Emission-Computed	1987
Positron emission tomography as an imaging tool in psychiatric disorders. Psychiatry research, 1989, Volume: 29, Issue:3 Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Huntington Disease; Tomography, Emission-Computed	1989
[F-18 FDG PET in dementia]. Rinsho hoshasen. Clinical radiography, 1989, Volume: 34, Issue:11 Topics: Adult; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed	1989
[Cerebral glucose metabolism in dementia (PET-FDG study)]. Rinsho hoshasen. Clinical radiography, 1989, Volume: 34, Issue:11 Topics: Adult; Aged; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed	1989
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989, Volume: 30, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Brain; Child; Color; Dementia; Deoxy Sugars; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hemophilia A; Homosexuality; Humans; Male; Tomography, Emission-Computed; Zidovudine	1989
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1989, May-25, Volume: 49, Issue:5 Topics: Aged; Aged, 80 and over; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed	1989
Positron emission tomography in Alzheimer's disease. Neurology, 1986, Volume: 36, Issue:7 Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Deoxyglucose; Electroencephalography; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychiatric Status Rating Scales; Psychological Tests; Rest; Temporal Lobe; Tomography, Emission-Computed; Tomography, X-Ray Computed	1986
Positron emission tomography and histopathology in Pick's disease. Neurology, 1987, Volume: 37, Issue:3 Topics: Aged; Brain; Choline O-Acetyltransferase; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose; Humans; Male; Tomography, Emission-Computed; Tomography, X-Ray Computed	1987
Positron emission tomography in aging and dementia: effect of cerebral atrophy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987, Volume: 28, Issue:4 Topics: Aged; Aged, 80 and over; Aging; Atrophy; Brain; Dementia; Deoxyglucose; Diagnostic Errors; Fluorine; Fluorodeoxyglucose F18; Humans; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed	1987
Behavioral activation and the variability of cerebral glucose metabolic measurements. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1987, Volume: 7, Issue:3 Topics: Aged; Aged, 80 and over; Arousal; Behavior; Brain; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Rest; Tomography, Emission-Computed	1987
The metabolic pathology of the AIDS dementia complex. Annals of neurology, 1987, Volume: 22, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Brain; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Tomography, Emission-Computed	1987
Determinations of cerebral glucose utilization in dementia using positron emission tomography. Danish medical bulletin, 1985, Volume: 32 Suppl 1 Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Blood Glucose; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed	1985
Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. Research publications - Association for Research in Nervous and Mental Disease, 1985, Volume: 63 Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxyglucose; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, X-Ray Computed	1985